You might also read
Articles linked to this work by shared authors, journal, and citation graph.
The use of alpha-chymotrypsin in cataract surgery significantly increases the risk of ocular hypertension, affecting 40.3% of patients compared to 25.3% without the enzyme. This pressure elevation persists for at least three weeks post-operation.
Area of Science:
Context:
Purpose:
Summary:
Impact: